Press Releases

CHICAGO, Oct. 30, 2019 /PRNewswire/ -- Outcome Health, a healthcare innovation company focused on supporting patients, caregivers and healthcare providers at the point of care, today announced it has entered into a non-prosecution agreement with the U.S. Department of Justice (DOJ) that resolves, with respect to the Company, the DOJ's criminal investigation related to pa

PASADENA, Calif., Oct. 30, 2019 /PRNewswire/ -- Huntington Hospital is one of America's 100 Best Hospitals for Cardiac Care and 100 Best for Coronary Intervention according to a national study by Hea

KANSAS CITY, Mo., Oct. 30, 2019 /PRNewswire/ -- CRB was recognized as the 2019 Company of the Year by the International Society for Pharmaceutical Engineering (ISPE) during the organization's annual meeting in Las Vegas, Nevada on Oct. 27–30, 2019.

In the news release, FCB Health Network Takes Best in Show and Large Agency of the Year at Medical Marketing & Media Awards, issued 14-Oct-2019 by FCB Health Network over PR Newswire, we are advised by the company that there were multiple changes made to the release. The complete, corrected release follows:FCB Health Network Takes Best in Show and Large Agency of the Year at Medical Marketin

Valens to produce a minimum of 2.2 million vape pens on behalf of BRNT Ltd. for the Canadian market over an initial two year termLargest publicly announced multi-year white label agreement to date for a branded finished product in the Canadian cannabis industry Gross revenue potential to Valens under the Agreement of over $

SAN FRANCISCO, Oct. 30, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter on Wednesday, November 6, 2019, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to revi

PHILADELPHIA, Oct. 30, 2019 /PRNewswire/ -- Vantage EyeCare, LLC is pleased to announce the addition of Dr. Allen Richmond to its Northe

NEWARK, Calif., Oct. 30, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that the first patient has been dosed in a Phase 2 study of PTG-300 in patients with polycythemia vera (PV), a myeloproliferative disorder characterized by overproduction of red blood cells."In addition to our ongoing study of PTG-300 in patients with beta-th

WASHINGTON, Oct. 30, 2019 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announces the launch of the #ChangeLungCancer social media campaign.  LUNGevity is proud to provide a new way for lung cancer advocates to get involved this November during Lung Cancer Awareness Month through this social media campaig

WASHINGTON, Oct. 30, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2019 and provide a general business overview, on Wednesday, November 6, 2019, after the market closes.  Vanda will host a conference call at 4:30 PM ET on